News & UpdatesNovoNordisk announces positive results with oral semaglutide
Novonordisk the leading Danish company for producing anti diabetic drugs announces positive results for phase II testing of the oral hypoglycemic semaglutide. In the trails semaglutide appeared to be safe and well tolerated with nausea and vomiting diminished over time. “We are very pleased with the results of this trial confirming the potential…
Feb 21, 2015
